Skip to main content
. 2014 Nov 14;4(11):e258. doi: 10.1038/bcj.2014.76

Figure 1.

Figure 1

PFS (a), Treatment-free survival (b) and overall survival (c) graphed for all patients (top row), according to response to therapy (middle row) and according to cytogenetic risk group, with Del(17p), Del(11q) or complex cytogenetics considered adverse (bottom row). Copyright: 123